Triaziquone - CISMeF

Preferred Label : Triaziquone;

NCIt definition : An aziridinylbenzoquinone-based alkylating agent with potential antineoplastic activity. The alkylating group in triaziquone becomes activated upon reduction of quinone to the hydroquinone form. This eventually results in the alkylation and crosslinking of DNA, thereby inhibiting DNA replication followed by an induction of apoptosis. In addition, reactive oxygen species may form during redox cycling which may contribute to this agent's cytotoxic activity.;

UNII : F3D5D9P25I;

InChIKey : PXSOHRWMIRDKMP-UHFFFAOYSA-N;

CAS number : 68-76-8;

Chemical formula : C12H13N3O2;

NSC code : 29215;

ChEBI ID : CHEBI:27090;

Codes from synonyms : NSC0029215;

Details

Origin ID

C903;

UMLS CUI

C0040878;

Automatic exact mappings (from CISMeF team)
- Triaziquone [ICHI extension code]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Triaziquone [ICD-11 Extension code]
- triaziquone [ATC Code]
- triaziquone [Substance BNPC]
- triaziquone [MeSH concept]
- triaziquone [MeSH Descriptor]
Validated automatic mappings to BTNT
- triaziquone [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients